Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Temperature Controlled Packaging Pharmaceutical Market Analysis

ID: MRFR//5724-CR | 170 Pages | Author: Snehal Singh| August 2022

The dynamics of temperature-controlled packaging market for the pharmaceutical industry are mainly shaped by an imperative fact : for the pharmaceutical products to retain the integrity and efficacy in the supply chain it is essential to maintain the temperature throughout the shipment. There is an expanding body of evidence that shows temperature control, especially in the transportation and storage of pharmaceuticals, could no longer be ignored because of the rise in complexity and biotechnology. This has thus developed a significant market for climate controlled packaging options such as insulation containers, cold chain solutions and thermal blankets in the process.

One of strong factors affecting market advancement is taking place as the global pharmaceutical industry is expands. Biomedical companies relocating to these new and previously unattended markets pose a greater issue in terms of transporting temperature-sensitive drugs. Furthermore, these reduce other post-production losses that arise in transit mode, thereby enabling more end-users to have access to pharmaceutical products.

Well, the presence of a strict policy framework implemented by health authorities as well as regulatory organizations have also been a key determinant factor for the market scenario. Organization like World Health Organization (WHO) and the USDA (FDA) have made guides that impose strict rules on the transportation and storing of pharmaceuticals, especially where temperatures need to be regulated. Compliance to this regulation is imperative, and passing it companies to which is “high-tech temperature controlled packaging” to save them from prevent the regulatory munts or pitfalls and safety patients.

The mark-up of biopharmaceuticals and specialty drugs in addition to the significance of cold chain is at the same time attributed to the increase in concern about temperature-sensitive packaging. Most of these drugs are very temperature-sensitive, therefore, even small deviations to the temperature they are stored at, can lead to losing their effectiveness. Therefore, both pharma companies and healthcare providers are deploying a range of automated tracking systems that guarantee preset temperature limits, continuous surveillance, and logging of data. This trend has brought into life the new and exciting developments in temperature-controlled packaging for the market with new technologies for smart and adaptable packages to match the growing requirements of the pharmaceutical sector.

COVID-19 pandemic is rapidly swaying the trends of environment-sensitive packaging as well. Since vaccines originally have to be stored and distributed, with the Pfizer and Moderna COVID-19 vaccines which do not tolerate temperatures change, it is obvious that reliable temperature logistics is a must. The demand for this novel technology is tremendous and it has sped-up investments in cold-chain infrastructure and into temperature – controlled packaging options for vaccines as well as other temperature-sensistive pharmaceuticals.

Covered Aspects:

Report Attribute/Metric Details
Segment Outlook Product, Type, Temperature Range, End-Use Industry, and Region

Global Temperature Controlled Packaging for Pharmaceutical Market Overview


Temperature Controlled Packaging for Pharmaceutical Market Size was valued at USD 6.7 billion in 2023. The temperature controlled packaging for pharmaceutical market industry is projected to grow from USD 7.1 Billion in 2024 to USD 10.4 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.8% during the forecast period (2024 - 2032). Rising prevalence of chronic disease incidents and growing number of clinical trials are the key market drivers enhancing the market growth.

Temperature Controlled Packaging for Pharmaceutical Market

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review


Temperature Controlled Packaging for Pharmaceutical Market Trends




  • Growing demand for fresh and frozen foods to boost market growth




The government's implementation of tight rules and regulations is anticipated to increase the efficiency of how pharmaceutical products are distributed. For instance, the Food & Drug Administration (US), Regulation 21 CFR 211.150 "Distribution procedures," states that pharmaceutical products must be shipped within appropriate temperatures and under accurate conditions in accordance with requirements. In addition, the regulation specifies that appropriate manual, electromechanical, or electronic temperature and humidity recording equipment, devices, and/or logs shall be used to document proper storage of prescription drugs.


Containerized cargo volumes at the Port of Mobile are expected to increase in 2021 as shippers look for uncrowded ports serving important North American markets. August saw a 34% rise in container volume via the Port compared to August 2020, while year-to-date tonnage saw a 27% increase. Part of that achievement may be attributed to a 37% rise in refrigerated containers as a result of the Port's almost $74 million investment in refrigerated facilities to serve cold cargo supply chains.


The market for temperature-controlled packaging solutions for pharmaceuticals is anticipated to rise as a result of expanding research and development initiatives around the world aimed at improving the manufacturing and packaging processes in the pharmaceutical and biotech industries. Along with pharmaceutical materials, the growing development of innovative medications and therapies such stem cells, r-proteins, and monoclonal antibodies has increased the demand for cold chain packaging systems at different phases of product development, driving market expansion. Therefore, such factors are enhanced the Temperature Controlled Packaging for Pharmaceutical market CAGR across the globe in the recent years.


Figure 1: Number of People With Chronic Conditions (in millions) Number of People With Chronic ConditionsSource: Secondary Research, Primary Research, MRFR Database and Analyst Review


However, to cater the demand there has been growth in chronic diseases patients. For instance, there has been a number of introductions of temperature controlled packaging for pharmaceutical is another factor driving the growth of the temperature controlled packaging for pharmaceutical market revenue.


Temperature Controlled Packaging for Pharmaceutical Market Segment Insights


Temperature Controlled Packaging for Pharmaceutical Product Insights


The temperature controlled packaging for pharmaceutical market segmentation, based on product, includes insulated shippers, and insulated containers. The insulated shipper segment held the majority share in 2021 contribution to around ~58-65% in respect to the  temperature controlled packaging for pharmaceutical market revenue. Applications across a wide range of industries, such as the pharmaceutical, food and beverage, and chemical sectors, are anticipated to increase shippers' convenience. As technology has advanced, there has been a continual rise in the demand for insulated shippers. For instance, the development of vacuum insulated panels (VIP) and phase change materials (PCMs) has allowed insulated shippers to provide a low-distribution temperature range. The delivery of pharmaceutical and therapeutic supplies has benefited greatly from these products.


Credo Cargo Pallet Shipper System, a reusable bulk shipper featuring cutting-edge slot-in components for simple loading and unloading, was introduced by Pelican Biothermal.


Temperature Controlled Packaging for Pharmaceutical Type Insights


The  temperature controlled packaging for pharmaceutical market segmentation, based on type, includes active systems and passive systems. The temperature controlled packaging for pharmaceutical market's active system segment is the largest by type. Active containers include active temperature control, which uses electric cooling or dry ice to keep the temperature inside the container within a set range. When compared to a passive system, the active system offers the maximum level of temperature accuracy. A costly alternative that offers a steady temperature for long-distance shipping is the active system. The supply chain delay can be effectively managed by the system. The presence of a power supply reduces the likelihood of temperature excursions. The active systems will be driven by the expanding transportation of bulk volume payload of medicinal items that require certain temperatures. Hence, the increasing number of shipping containers are anticipated to aids the market growth.


Figure 2:  Temperature Controlled Packaging for Pharmaceutical Market, by Type, 2021 & 2030 (USD Million)Temperature Controlled Packaging for Pharmaceutical Market, by Type, 2021 & 2030Source: Secondary Research, Primary Research, MRFR Database and Analyst Review


Temperature Controlled Packaging for Pharmaceutical End User Insights


Based on End Users, the  temperature controlled packaging for pharmaceutical market data has been segmented into pharmaceutical and clinical trails. Pharmaceutical accounts the largest segment share in 2021, owing to the growing demand for medicines throughout the world, and increasing number of chronic disease patients. Moreover, increasing government initiatives to improve the healthcare infrastructure, and the expansion of pharmaceutical industry is expected to bolster at a significant CAGR during the forecast period.


Temperature Controlled Packaging for Pharmaceutical Regional Insights


By Region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. North America temperature controlled packaging for pharmaceutical market accounted for USD 4.42 billion in 2021 and is expected to exhibit a significant CAGR of 43.80% growth during the study period. This is attributed to the growing incidence of chronic diseases, and increasing number of clinical trials, as well as an ageing population across the region.


Further, the major countries studied in the temperature controlled packaging for pharmaceutical market report are: The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.


Figure 3:  Temperature Controlled Packaging for Pharmaceutical MARKET SHARE BY REGION 2021 (%)Temperature Controlled Packaging for Pharmaceutical MARKET SHARE BY REGIONSource: Secondary Research, Primary Research, MRFR Database and Analyst Review


Europe temperature controlled packaging for pharmaceutical market accounts for the second-largest market share due to the availability of cutting-edge treatment facilities, government backing for the growth of the healthcare industry, an ageing population, and an increase in incidence of chronic disease, and osteoarthritis. Further, the Germany temperature controlled packaging for pharmaceutical market held the largest market share, and the UK temperature controlled packaging for pharmaceutical market was the fastest growing market in the European region


The Asia-Pacific temperature controlled packaging for pharmaceutical Market is expected to grow at the fastest CAGR from 2022 to 2030. This is due to increased population, rising spending on healthcare infrastructure, and others. Moreover, China temperature controlled packaging for pharmaceutical market held the largest market share, and the India temperature controlled packaging for pharmaceutical market was the fastest growing market in the Asia-Pacific region.


Temperature Controlled Packaging for Pharmaceutical Key Market Players & Competitive Insights


Major market players are spending a lot of money on R&D to increase their product lines, which will help the temperature controlled packaging for pharmaceutical market grow even more. Temperature controlled packaging for pharmaceutical market participants are also taking a range of strategic initiatives to grow their worldwide footprint, with key market developments such as mergers and acquisitions, contractual agreements, increased investments, new product launches, and collaboration with other organizations. Competitors in the temperature controlled packaging for pharmaceutical industry must offer cost-effective items to expand and survive in an increasingly competitive and rising temperature controlled packaging for pharmaceutical market environment.


One of the primary business strategies adopted by manufacturers in the temperature-controlled packaging for pharmaceutical industry to benefit clients and expand the market sector is to manufacture locally to reduce operating costs. In recent years, temperature controlled packaging for pharmaceutical industry has provided medicine with some of the most significant benefits. The temperature controlled packaging for pharmaceutical market major player such as Softbox Systems (UK), FedEx Corporation (US), Sofrigam SA (France), Envirotainer AB (Sweden), DGP Intelsius GMBH (UK), and others are working to expand the market demand for temperature controlled packaging for pharmaceutical by investing in research and development activities.


Softbox Systems is engaged in manufacturing of thermal coverings and packaging systems with temperature controls for the life science sector. For the biotechnology and pharmaceutical industries, the company develops and manufactures high-performance passive temperature control packaging solutions. These solutions are intended to protect the quality of temperature-sensitive medicines, vaccines, and active pharmaceutical ingredients ("API") during distribution. For instance, in October 2022, the most comprehensive provider of active and passive temperature-controlled shipping solutions for the pharmaceutical industry, CSafe, has introduced CSafeAPS, a new, high-tech reusable pallet shipper.


Also, FedEx offers business, e-commerce, and transportation services. FedEx Express, FedEx Ground, FedEx Freight, and FedEx Services make up its four operating segments. Deliveries of parcels and freight can be made using the shipping services provided by the FedEx Express division. The FedEx Ground sector provides money-back guaranteed ground package delivery services for commercial and residential customers, as well as consolidates and delivers. In August 2019, FedEx Express has introduced improved temperature-controlled shipping options that allow customers to pack their international shipments at their place of business. With the service, FedEx will provide two distinct packaging options. The va-Q-one is a highly sought-after service among customers in the healthcare industry and is for temperature ranges of minus 25°C to minus 15°C, 2°C to 8°C, and 15°C to 25°C. The box comes in five various sizes with a capacity ranging from 4 to 74 litres, and it uses coolants to maintain its temperature for 96 hours.


List of the Key Companies in the temperature controlled packaging for pharmaceutical market includes



Temperature Controlled Packaging For Pharmaceutical Industry Developments


March 2021: By establishing new regional offices in the Netherlands, Cold Chain Technologies intended to increase the market for its temperature-controlled systems in the EMEA (Europe, the Middle East, and Africa) region.


November 2020: EOS line of parcel shippers was introduced by Sonoco Products Company. The product's temperature control packaging system is recyclable.


November 2020: For the purpose of distributing COVID-19 vaccinations, Cold Chain Technologies plans to construct a new plant in Lebanon, United States.


Temperature Controlled Packaging For Pharmaceutical Market Segmentation


Temperature Controlled Packaging For Pharmaceutical Product Outlook



  • Insulated Shippers

  • Insulated Containers


Temperature Controlled Packaging For Pharmaceutical Type Outlook



  • Active Systems

  • Passive Systems


Temperature Controlled Packaging For Pharmaceutical Temperature Range Outlook



  • Up to 10°C

  • 10°C to 20°C

  • More than 20°C


Temperature Controlled Packaging For Pharmaceutical End-Use Industry Outlook



  • Pharmaceutical

  • Clinical Trial


Temperature Controlled Packaging For Pharmaceutical Regional Outlook



  • North America

    • US

    • Canada



  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe



  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Australia

    • Rest of Asia-Pacific



  • Rest of the World

    • Middle East

    • Africa

    • Latin America



Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.